1-3 of 3
Nisha Patel
Close
Sort by
Journal Articles

Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30 + lymphomas: results of a phase 1 trial

Clinical Trials & Observations
Jennifer N. Brudno, Danielle A. Natrakul, Jeremiah Karrs, Nisha Patel, Roberto Maass-Moreno, Mark A. Ahlman, Lekha Mikkilineni, Jennifer Mann, David F. Stroncek, Steven L. Highfill, Genevieve C. Fromm, Rashmika Patel, Stefania Pittaluga, James N. Kochenderfer
Journal: Blood Advances
Blood Adv (2024) 8 (3): 802–814.
https://doi.org/10.1182/bloodadvances.2023011470
Published: 2024
Includes: Supplemental data
Journal Articles

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Clinical Trials & Observations
Ifeyinwa Emmanuela Obiorah, Bhavisha A. Patel, Emma M. Groarke, Weixin Wang, Megan Trick, Amanda K. Ombrello, Marcela A. Ferrada, Zhijie Wu, Fernanda Gutierrez-Rodrigues, Jennifer Lotter, Lorena Wilson, Patrycja Hoffmann, Daniela Ospina Cardona, Nisha Patel, Alina Dulau-Florea, Daniel L. Kastner, Peter C. Grayson, David B. Beck, Neal S. Young, Katherine R. Calvo
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3203–3215.
https://doi.org/10.1182/bloodadvances.2021004976
Published: 2021
Includes: Supplemental data
Journal Articles

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction

Clinical Trials & Observations
Claudia Hanni, Elizabeth Petrovitch, Mona Ali, Whitney Gibson, Christopher Giuliano, Jenna Holzhausen, Charles Makowski, Amy Pallisco, Nisha Patel, Denise Sutter, Long To, Raymond Yost
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2366–2371.
https://doi.org/10.1182/bloodadvances.2019000972
Published: 2020